Vaniprevir
id:
vaniprevir-279-934762
title:
Vaniprevir
text:
Vaniprevir (MK-7009) is a macrocyclic hepatitis C virus (HCV) NS3/4A protease inhibitor, developed by Merck & Co., which is currently in clinical testing. In Japan, it was approved for treating hepatitis C in 2014 under the brand name Vanihep.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Vaniprevir
date created:
date modified:
2023-12-01T20:58:39Z
main entity:
{"identifier":"Q7914945","url":"https://www.wikidata.org/entity/Q7914945"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/d/d6/Vaniprevir.svg","width":512,"height":342}
fields total:
13
integrity:
15